Mary Tagliaferri
CIK: 0001323304
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About TAGLIAFERRI MARY
TAGLIAFERRI MARY (SEC CIK 0001323304) files insider reports with the SEC as Director of Iambic Therapeutics, Inc. (IAM) and Director of ADARx Pharmaceuticals, Inc. (ADRX).
Signal8 holds 3 ownership filings by TAGLIAFERRI MARY (2 Form 3, 1 Form 4), filed between Sep 24, 2026 and Oct 16, 2026. Those filings report 1 transaction, the latest on Oct 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on TAGLIAFERRI MARY's filings is in SAN DIEGO, CA.
Recent filings by TAGLIAFERRI MARY
- Oct 14, 2026: Grant or award of IAM derivative securities (Form 4, code A).
Other insiders filing for Iambic Therapeutics, Inc. (IAM)
- Catalio Capital Management, LP, 10% Owner
- Vogelstein R Jacob, Director
- Secora Michael, CFO & Chief Corp Dev Ofcr
- RASTETTER WILLIAM H, Director
- Rachlin Evan Lockwood, Director
- EMSTER KURT VON, Director